Virtus Nutrition Private Limited

In their own words

Genomics and Healthcare: The launch of the Human Genome Project in the 1990s and subsequently, mapping of human DNA ushered in the ‘era of big science’ and jumpstarted the field of genomics that explains the relationship between genetics, health and lifestyle. Many deem it to be the ‘next big thing’ to fight lifestyle-linked diseases and critical illnesses. However, most of the genomic data available today represents the Caucasian population. Even though India inhabits about 17% of the world’s population, the Indian population is not well represented in the scientific community. Moreover, there is an exponential rise in non-communicable diseases in India. Genomics will play a very important role in enabling better prevention, diagnosis and treatment interventions. There are very few companies in India who have the insight, capability and focus as The Gene Box (TGB) to make a similar impact on the healthcare through genomics. TGB’s aim is to create value for Indian genomics data, and better represent the Indian population in the scientific data community. TGB is a product of Virtus Nutrition Private Limited, a pioneering health-tech company. The company was founded in 2015 by Pranav Anam, a geneticist with an aim to translate genomic information into meaningful insights. TGB is headquartered in Mumbai and has partners across the globe. It is committed to empowering healthcare providers and researchers with state-of-the-art genomics innovation. Strategic partnerships with global organizations have helped TGB further cement its place in the industry. TGB Services: TGB is a unique platform that businesses can use for a wide range of purposes. As a result, a good share of the revenue comes from businesses who subscribe to our research and report platforms. Reports: TGB has an innovative, revolutionary data-to-reports platform that enables the translation of genomics to meaningful insights. This report generation engine is powered by a proprietary algorithm and predictive risk scoring technology. When it comes to healthcare, personalization is the key - the trial and error routine associated with a typical ‘One Size Fits All’ approach is obsolete. TGB collaborates with nutritionists, fitness experts, healthcare providers to enable interventions through genomic reports. Research: Whether it is to understand the prevalence of a condition via population-based studies from a genetic standpoint or to explore genetic-based interventions, TGB’s in-house team of researchers and data scientists deliver the best-in-industry analytics. Recommendations: TGB excels in interpreting genetic data into meaningful solutions. We intend to deploy artificial intelligence (AI) and machine learning (ML) for better healthcare products. TGB Team: Pranav Anam, Founder & CEO, is qualified geneticist from Newcastle University, United Kingdom, Pranav’s greatest strength is his ability and agility in setting up and steering large global teams across diverse businesses. He has successfully developed a unique pan-India commercial and collaborative platform to help stem cell scientists, academicians, and medical practitioners create best-in-class therapeutic products and services. At TGB, Pranav plays the critical role of a catalyst and business accelerator. On the one hand, he spearheads the firm’s business development and strategic alliances, on the other; he actively coordinates with the product development and engineering teams towards continually enhancing TGB’s unique value proposition and expanding its wide range of offerings. TGB team is built on the foundation of a core Research and Data Science team. TGB houses bright minds from all over the country including PhDs, doctors, IITians, post-grads all belonging to reputable institutes. TGB is also supported by an enterprising Marketing and Communications team which works towards partnering with healthcare enablers and delivering the right training and communication. What the future holds for TGB: The dearth of genomics data pertaining to India points at an unmet need and offers an enormous opportunity for us. India’s diversity is an asset and we aim to serve Indians with the benefits of their genetic information. We hope that the insights created by TGB’s platform will drive the healthcare industry into precision medicine and care in multiple domains – applications of genomics data are varied and can span from personalized nutrition & fitness plans to medicine, nutraceuticals, cosmetics, FMCG products, improved interventions for better management of lifestyle so on and so forth. The Global Genomics Market is expected to rise at an exponential CAGR of 18.7% between 2018 and 2026. It is clear that India will play a major role in unfolding the revolution in healthcare genomics in the APAC region and there is no doubt that TGB will be taking a leading role in Asia’s genomics space.

Written by the company on its public Startup India profile. Not verified by us.

Is this your company?

Everything here comes from public government records. If something is wrong, the authoritative place to correct it is the Startup India portal itself, and we will pick the correction up on the next monthly snapshot. To flag an error on our side, use the report link or write to trust@indianstartupmap.com.

How we built this page Where the data comes from How you may reuse it